Literature DB >> 11705813

Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice.

J Chen1, P J Kuhlencordt, J Astern, R Gyurko, P L Huang.   

Abstract

BACKGROUND: Apolipoprotein E (apoE)/endothelial nitric oxide synthase (eNOS) double knockout (DKO) mice demonstrate accelerated atherosclerosis and develop abdominal aortic aneurysms and aortic dissection, suggesting a role for eNOS in suppressing atherogenesis. To test whether accelerated atherosclerosis and aortic aneurysms were due to hypertension, we administered hydralazine to male apoE/eNOS DKO mice to reduce blood pressure. METHODS AND
RESULTS: Male apoE/eNOS DKO mice were treated with hydralazine in their drinking water (250 mg/L) using a dose that lowers the blood pressure to levels seen in apoE KO mice. The mice were fed a Western-type diet for 16 weeks, and lesion formation was assessed by inspection of the vessel and staining with Sudan IV. Hydralazine-treated, normotensive male apoE/eNOS DKO mice developed increased aortic lesion areas (30.0+/-2.8%, n=11) compared with male apoE KO mice (14.6+/-0.8%, n=7). The extent of lesion formation was not significantly different from male apoE/eNOS DKO mice that were not given hydralazine (28.3+/-3.1%, n=9). Four of 11 hydralazine-treated male apoE/eNOS DKO mice developed abdominal aortic aneurysms.
CONCLUSIONS: Hypertension is not required for the accelerated atherosclerosis seen in apoE/eNOS DKO animals, and control of hypertension during a 16-week period does not prevent aortic aneurysm formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705813     DOI: 10.1161/hc4501.099729

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

1.  PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.

Authors:  Patrizia Nigro; Jun-ichi Abe; Chang-Hoon Woo; Kimio Satoh; Carolyn McClain; Michael R O'Dell; Hakjoo Lee; Jae-Hyang Lim; Jian-dong Li; Kyung-Sun Heo; Keigi Fujiwara; Bradford C Berk
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

Authors:  Johannes Jacobi; Renke Maas; Arturo J Cardounel; Michaela Arend; Arthur J Pope; Nada Cordasic; Juliane Heusinger-Ribeiro; Dorothee Atzler; Joachim Strobel; Edzard Schwedhelm; Rainer H Böger; Karl F Hilgers
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 3.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Authors:  Louis J Ignarro; Claudio Napoli
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

4.  Animal model of left atrial thrombus in congestive heart failure in rats.

Authors:  Jiqiu Chen; Benjamin Strauss; Lifan Liang; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

Review 5.  Endothelial nitric oxide synthase and endothelial dysfunction.

Authors:  Paul L Huang
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

6.  Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow.

Authors:  Doyon Won; Su-Ning Zhu; Mian Chen; Anouk-Martine Teichert; Jason E Fish; Charles C Matouk; Michael Bonert; Matadial Ojha; Philip A Marsden; Myron I Cybulsky
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

7.  Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

Authors:  Yujun Cai; Jian-Dong Li; Chen Yan
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

Review 8.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Authors:  Louis J Ignarro; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

9.  Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals.

Authors:  Atif Zaheer; Monzur Murshed; Alec M De Grand; Timothy G Morgan; Gerard Karsenty; John V Frangioni
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-16       Impact factor: 8.311

10.  Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.

Authors:  Peter J Kuhlencordt; P Padmapriya; S Rützel; J Schödel; K Hu; A Schäfer; P L Huang; G Ertl; J Bauersachs
Journal:  Atherosclerosis       Date:  2008-04-06       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.